- Home
- IMMX vs RRGB Comparison
IMMX vs RRGB Comparison
Compare IMMX & RRGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- RRGB
- Stock Information
- Founded
- IMMX 2014
- RRGB 1969
- Country
- IMMX United States
- RRGB United States
- Employees
- IMMX N/A
- RRGB N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- RRGB Restaurants
- Sector
- IMMX Health Care
- RRGB Consumer Discretionary
- Exchange
- IMMX Nasdaq
- RRGB Nasdaq
- Market Cap
- IMMX 82.6M
- RRGB 88.7M
- IPO Year
- IMMX 2021
- RRGB 2002
- Fundamental
- Price
- IMMX $3.28
- RRGB $4.42
- Analyst Decision
- IMMX Strong Buy
- RRGB Strong Buy
- Analyst Count
- IMMX 1
- RRGB 2
- Target Price
- IMMX $8.00
- RRGB $11.00
- AVG Volume (30 Days)
- IMMX 769.8K
- RRGB 287.5K
- Earning Date
- IMMX 11-07-2025
- RRGB 11-10-2025
- Dividend Yield
- IMMX N/A
- RRGB N/A
- EPS Growth
- IMMX N/A
- RRGB N/A
- EPS
- IMMX N/A
- RRGB N/A
- Revenue
- IMMX N/A
- RRGB $1,226,409,000.00
- Revenue This Year
- IMMX N/A
- RRGB N/A
- Revenue Next Year
- IMMX N/A
- RRGB N/A
- P/E Ratio
- IMMX N/A
- RRGB N/A
- Revenue Growth
- IMMX N/A
- RRGB N/A
- 52 Week Low
- IMMX $1.34
- RRGB $2.50
- 52 Week High
- IMMX $4.05
- RRGB $7.89
- Technical
- Relative Strength Index (RSI)
- IMMX 55.27
- RRGB 19.92
- Support Level
- IMMX $2.85
- RRGB $4.60
- Resistance Level
- IMMX $3.53
- RRGB $5.32
- Average True Range (ATR)
- IMMX 0.38
- RRGB 0.33
- MACD
- IMMX -0.07
- RRGB -0.11
- Stochastic Oscillator
- IMMX 34.80
- RRGB 6.72
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.